Risk factors of medication-related osteonecrosis of the jaw: a retrospective study in a Turkish subpopulation

Creative Commons License

ŞAHİN O., Odabasi O. , Aliyev T., Tatar B.

JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, vol.45, no.2, pp.108-115, 2019 (Journal Indexed in ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 45 Issue: 2
  • Publication Date: 2019
  • Doi Number: 10.5125/jkaoms.2019.45.2.108
  • Title of Journal : JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS
  • Page Numbers: pp.108-115

Abstract

Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a well-known side effect of certain drugs that are used to influence bone metabolism to treat osteometabolic disease or cancers. The purpose of our study was to investigate how high-concentration and low-concentration bisphosphonate (BP) intake affects the disease severity.